Quantum BioPharma adds $1m in Bitcoin to treasury, eyes future crypto financing

Quantum BioPharma Ltd., a Nasdaq-listed biotech and medical research company, has purchased $1 million in Bitcoin and other cryptocurrencies as part of a strategic move approved by its board of directors.

The company plans to allow future financings and transactions in cryptocurrency, signaling confidence in the evolving crypto market.

The company disclosed that the cryptocurrency assets are held with a compliant custodian to ensure adherence to financial and audit regulations. Its leadership believes the investment aligns with the growing legitimacy of digital assets and the potential for shareholder returns.

Zeeshan Saeed, CEO of Quantum BioPharma, cited advancements in Bitcoin’s (BTC) legal status and market acceptance as key factors behind the decision.

He also pointed to renewed optimism for crypto policies under President-elect Donald Trump and the introduction of Bitcoin-based exchange-traded funds by global asset managers.

“We are exploring innovative ways to grow our capital not being used in operations,” Saeed said in a statement.

The company emphasized its commitment to monitoring market conditions and adjusting its cryptocurrency holdings as needed. This marks Quantum BioPharma’s entry into a growing trend where traditional companies diversify assets with Bitcoin and other digital currencies to capitalize on emerging financial trends.

Bitcoin reserves the new business norm?

This move comes amid a broader institutional shift toward crypto adoption, as businesses and asset managers increasingly integrate digital assets into their financial strategies.

Travala, a crypto-based travel booking platform, also recently introduced a Treasury Reserve Plan after exceeding $100 million in annual revenue. The plan involves holding reserves in Bitcoin and its native token to bolster financial stability and growth.

Genius Group also expanded its Bitcoin treasury by acquiring194 Bitcoin for $18 million at an average price of $92,728 per Bitcoin. The move aligned with its “Bitcoin-first” strategy, which aims to allocate 90% of reserves to Bitcoin with a $120 million target.